• Regulus Therapeutics Inc. or Regulus (Nasdaq: RGLS) is a clinical stage biopharmaceutical company focused on the development of first-in-class drugs that...
    5 KB (346 words) - 07:14, 29 February 2024
  • Thumbnail for William Rastetter
    CEO (2017) and chair (2017-2018). Rastetter is also a director of Regulus Therapeutics and Entos, Inc.. He was a partner in the venture firm Venrock (2006-2013)...
    28 KB (2,503 words) - 17:41, 6 April 2024
  • Thumbnail for New Enterprise Associates
    Moda Operandi, MongoDB, Pager, Patreon, Philo, Plaid, Raise.com, Regulus Therapeutics, Robinhood Markets, Rock Health, Smartcar, Splashtop, Tamara Mellon...
    9 KB (820 words) - 18:34, 19 May 2024
  • Thumbnail for Ionis Pharmaceuticals
    which focuses on RNA interference, formed a 50/50 joint venture, Regulus Therapeutics, to apply their intellectual property and knowledge around oligomer...
    16 KB (1,420 words) - 16:10, 5 June 2024
  • with Ionis Pharmaceuticals to found the company Regulus Therapeutics, focused on microRNA therapeutics. In 2009, the company formed alliances with Cubist...
    20 KB (1,743 words) - 17:48, 29 May 2024
  • Thumbnail for David Baltimore
    directors at several companies and non-profit institutions including Regulus Therapeutics and Appia Bio. He has also been a member of numerous Scientific Advisory...
    80 KB (8,302 words) - 08:34, 11 June 2024
  • Thumbnail for Orders of magnitude (length)
    light-years – Distance to Aldebaran 750 Pm – 79.36 light-years – Distance to Regulus 900 Pm – 92.73 light-years – Distance to Algol 946 Pm – 1 light-century...
    173 KB (16,319 words) - 10:32, 16 June 2024